Sunday, November 10, 2013

The End of Dual Therapy with Renin–Angiotensin–Aldosterone System Blockade? — NEJM

The End of Dual Therapy with Renin–Angiotensin–Aldosterone System Blockade? — NEJM

1 comment:

  1. no dual blockade in diabetics/DN.. no confusion..
    what about non diabetics with or without CKD, for control of BP with monitoring of potassium? based on ONTARGET, VALIANT, CHARM.. Thoughts on the BP response in these trials and your practice
    Thanks

    ReplyDelete